Large and micro coronary vascular involvement in diabetes

Pharmacological Reports

Volumn 57, Issue SUPPL., 2005, Pages 3-9

  L'Abbate, Antonio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Coronary artery disease in diabetics; Coronary endothelial dysfunction; Coronary microvascular dysfunction; Myocardial perfusion scintigraphy

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN;

ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MICROCIRCULATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; VASCULAR DISEASE;

EID: 33645657625     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NRANES III participants age 50 years and older. Diabetes, 2003, 52, 1210-1214.
2. Borghi C, Bacchelli S, Esposti DD, Ambrosioni E: SMILE Study. Effects of the early ACE inhibition in diabetic nonthrombolyzed. patients with anterior acute myocardial infarction. Diabetes Care, 2003, 26, 1862-1868.
3. Casella G, Savonitto S, Chiarella F, Gonzini L, Di Chiara. A, Bolognese L, De Servi S et al.: Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study. Ital Heart J,2005, 6, 374-383.
4. Castells I, Salinas I, Rius F, Fraile M, Rubio L, Pereferrer. D, Romero R et al.: Inducible myocardial ischemia in asymptomatic Type 2 diabetic patients. Diabetes Res Clin Pract, 2000, 49, 127-133
5. Cosson E, Paycha F, Paries J, Cattan S, Ramadan A, Mcddah D, Attali JR et al.: Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?. Diabet Med, 2004, 21, 342-348.
6. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR: Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol, 2002, 90, 827-832.
7. DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Inter Med, 2001, 161, 397-405.
8. Di Carli F, Janisse J, Grunberger G, Ager J: Role of chronic hyperglicemia in the pathogenesis of coronary microvascular dysfunction in diabetes. JACC, 2003, 41, 1387-1393,
9. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P: Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients. Diabetes Care, 2002, 25, 1418-1424.
10. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998, 339, 229-234.
11. Iozzo P, Chareonthaitawee P, Di Terlizzi M, Betteridge DJ, Ferrannini E, Camici PG: Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab, 2002, 282, El 163-1171.
12. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care, 1999, 22, 1396-1400.
13. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, Hachamovitch R et al: Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J, 1999, 138, 1025-1032.
14. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C: Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab, 2000, 26, 387-392.
15. Kjaer A, Meyer C, Nielsen FS, Parving HH, Hesse B: Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes. J Nucl Med, 2003, 44, 19-23.
16. Kranidis A, Zamanis N, Mitrakou A, Patsilinakos S, Bouki T, Tountas N, Anthopoulos P et al.: Coronary microcirculation evaluation with transesophageal echocardiography Doppler in type II diabetics. Int J Cardiol, 1997, 59, 119-124.
17. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Umemura T et al.: Diabetes mellitus is associated with insufficient microvascular reperfusion following revascularization for anterior acute myocardial infarction. Intern Med, 2003,42, 554-559.
18. L'Abbate A, Sambuceti G, Haunsr̂ S, Schneider-Eicke J: Methods for evaluating coronary microvasculature in humans. Eur Heart J, 1999, 20, 1300-1313.
19. Le Feuvre C, Raoux F, Beygui F, Helft G, Mogenet A, Dubois-Laforgue D, Timsit J et al.: Cumulative adverse effects of diabetes mellitus and hypertension on coronary flow velocity reserve. Arch Mal Coeur Vaiss, 2004, 97, 849-854.
20. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M et al.: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation, 1995, 91, 1659-1668.
21. Levantesi G, Macchia A, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C et al: Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol, 2005, 46, 277-283.
22. Meyer C, Schwaiger M: Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol, 1977, 80, 94A-101A,
23. Milan Study on Atherosclerosis and Diabetes Group: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic factors in noninsulin-dependent diabetes mellitus. Am J Cardiol, 1997, 79, 134-139.
24. Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC, Gutterman DD: Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res, 2003, 92, 151-158.
25. Moreno PR, Fuster V: New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol, 2004, 44, 2293-2300.
26. Moreno R, Hernandez-Antolin R, Alfonso F, Macaya C: Diabetes mellitus and acute myocardial infarction: more data supporting a poorer microvasculature reperfusion. Am Heart J, 2003, 146, E6.
27. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290, 1884-1890
28. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD: Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation, 1995, 91, 635-640.
29. Natali A, Vichi S, Landi P, Severi S, L'Abbate A, Ferrannini E: Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia, 2000, 43, 632-641.
30. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III):Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002, 106, 3143-3421.
31. Nesto RW, Zarich S: Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition. Editorial. Circulation, 1998, 97, 12-15.
32. Nitenberg A, Ledoux S, Valensi P, Sachs R, Antony I: Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients. Diabetes, 2002, 51, 813-818.
33. Nitenberg A, Ledoux S, Valensi P, Sachs R, Attali JR, Antony I: Impairment of coronary microvascular dilation in response to cold pressor-induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes, 2001, 50, 1180-1185.
34. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR: Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes, 1993, 42, 1017-1025.
35. Quinones MJ, Hemandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenes X, Hernandez G, De La Rosa R et al: Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Int Med, 2004, 140, 700-708.
36. Rajagopalan N, Miller T, Hodge D, Frye R, Gibbons R: Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. JACC, 2005, 45, 43-48.
37. Schnell O: Cardiac sympathetic innervation and blood flow regulation of the diabetic heart. Diabetes Metab Res Rev, 2001, 17, 243-245.
38. Scognamiglio R, Negut C, Vigili De Kreutzenberg S, Tiengo A, Avogaro A: Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation, 2005, 112, 179-184.
39. Stamler J, Vaccaro O, Neaton J, Wentworth D: Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the multiple Risk Factor Intervention Trial. Diabetes Care, 1993, 16, 434-444.
40. Sundell J, Laine H, Nuutila P, Ronnemaa T, Luotolahti M, Raitakari O, Knuuti J: The effects of insulin and short term hyperglycemia on myocardial blood flow in young men with uncomplicated Type 1 diabetes. Diabetologia, 2002, 45, 775-782.
41. Sundell J, Ronnemaa T, Laine H, Raitakari OT, Luotolahti M, Nuutila P, Knuuti J: High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes. Diabetologia, 2004, 47, 1888-1894.
42. Wackers FJ: Diabetes and coronary artery disease: the role of stress myocardial perfusion imaging. Cleve Clin J Med, 2005, 72, 21-25, 29-33.
43. Wackers FJ Th, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R et al.: For the detection of Ischemia in asymptomatic diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care, 2004, 27, 1954-1961.
44. Werner GS, Richartz BM, Heinke S, Ferrari M, Figulla HR: Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J, 2003, 24, 1134-1142.
45. Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, Deychak Y et al.: Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol, 1996, 28, 1661-1669.
46. Yokoyama I, Momomura S, Ohtake T, Yonekura Y, Nishikawa J, Sasaki Y, Omata M: Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol, 1997, 30, 1472-1477.
47. Zuanetti G, Latini R, Maggioni AP~ Franzosi M, Santoro L, Tognoni G: Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study, Circulation, 1997, 96, 4239-4245.
48. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG: Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol, 1993, 22, 1788-1794.